Lv1
100 积分 2022-04-24 加入
Drug-Induced Thrombocytopenia: Mechanisms and Laboratory Diagnostics
4小时前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
15天前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
1个月前
已完结
Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment
1个月前
已完结
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
1个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
2个月前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
2个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
2个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
皖公网安备34019202002308
